NDC 73309-031-03 - Temozolomide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-031
- Requested NDC
- 73309-031-03
- Package NDCs from labels
- 73309-031-01, 73309-031-02, 73309-031-03
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-02-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Temozolomide - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-02-24 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-031-01 | Temozolomide | 100 g in 1 JAR | POWDER | 100 | 3 | |
| 73309-031-02 | Temozolomide | 50 g in 1 JAR | POWDER | 50 | 3 | |
| 73309-031-03 | Temozolomide | 25 g in 1 JAR | POWDER | 25 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | 9dff10ec-6a55-47b6-a458-b7c39e32dc55 | 2026-08-27 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | f6d762ea-fff0-43e8-b67d-bef19e883dd8 | 2026-08-27 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | f743f7e0-74cf-47e5-bf21-f2b75d2596dc | 2026-08-27 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | b3f69c67-db30-4266-8075-9b18c71c9fc1 | 2026-08-27 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | CivicaScript LLC | 56245d21-4a42-471e-bbdc-80b129336e2f | 2026-08-11 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 79766855-2533-43b1-b60e-1e9daecadad5 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 021b97cc-a76f-44b6-b7be-670d2ae83690 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | c0f2077c-48e6-452e-9f88-e1f2c89df0a2 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 38f17780-8037-44a0-9e84-b7150c9bde12 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 6eb0bd33-582f-43a6-a607-e72b4390c6d3 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | a147b361-262c-49c6-9b8e-7e454f755721 | 2026-06-09 | Warnings, Adverse reactions | YF1K15M17Y |
| TEMODAR | TEMOZOLOMIDE | Merck Sharp & Dohme LLC | 046a9011-3911-4d3f-a15f-fbb56d5aad56 | 2026-02-20 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Sun Pharmaceutical Industries, Inc. | c1e05c21-a411-4493-80de-ede373632475 | 2025-11-14 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Accord Healthcare Inc. | 2d599ccf-8e63-4ff1-aa52-4809744ea97a | 2025-05-23 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Ascend Laboratories, LLC | 33d67bce-38ae-45fc-a858-d51167b0ecfd | 2025-01-09 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Devatis, Inc. | 6b263fe0-5f06-4889-bf14-4aa185470810 | 2024-11-30 | Warnings, Adverse reactions | YF1K15M17Y |
| TEMOZOLOMIDE | TEMOZOLOMIDE | Camber Pharmaceuticals, Inc. | 78c12889-c837-40c1-8f85-4d048008ad29 | 2024-10-19 | Warnings, Adverse reactions | YF1K15M17Y |
| TEMOZOLOMIDE | TEMOZOLOMIDE | Rising Pharma Holdings, Inc. | 70996a9d-4a4f-4ed1-ab07-130486aa14ab | 2024-07-25 | Warnings, Adverse reactions | YF1K15M17Y |
| Temozolomide | TEMOZOLOMIDE | Amneal Pharmaceuticals LLC | 6c8529ec-8936-4fec-a1a5-2b285c7e4859 | 2024-02-17 | Warnings, Adverse reactions | YF1K15M17Y |
| temozolomide | TEMOZOLOMIDE | Nivagen Pharmaceuticals, Inc. | 27e5a781-e4f2-4489-9def-7971d0b86d9c | 2021-11-28 | Boxed warning, Warnings, Adverse reactions | YF1K15M17Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.